Tissue Regenix was established in May 2006 and is dedicated to the development of clinical solutions to address the chronic shortfalls in donor tissue availability in areas such as Vascular and Orthopaedic medicine. There is a well established clinical need for more donor tissue for many surgical procedures. Tissue Regenix will develop and commercialise acellular tissue repair products to meet this need, to ultimately benefit patients.
Type
Public
HQ
Swillington, GB
Founded
2006
Size (employees)
80 (est)+15%
Tissue Regenix Group was founded in 2006 and is headquartered in Swillington, GB
Report incorrect company information

Tissue Regenix Group Office Locations

Tissue Regenix Group has offices in Swillington and San Antonio
Swillington, GB (HQ)
Astley Way
San Antonio, US
2611 North Loop 1604 W
Show all (2)
Report incorrect company information

Tissue Regenix Group Financials and Metrics

Tissue Regenix Group Financials

Tissue Regenix Group's revenue was reported to be £816 k in FY, 2016 which is a 716% increase from the previous period.
GBP

Revenue (FY, 2016)

816 k

Revenue growth (FY, 2015 - FY, 2016), %

716%

Gross profit (FY, 2016)

662 k

Gross profit margin (FY, 2016), %

81.1%

Net income (FY, 2016)

(9.5 m)

EBITDA (FY, 2016)

(10 m)

EBIT (FY, 2016)

(10.2 m)

Market capitalization (11-Sep-2017)

98.5 m

Closing share price (11-Sep-2017)

0.1

Cash (31-Jan-2016)

19.9 m
Tissue Regenix Group's current market capitalization is £98.5 m.
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

7 k49 k6 k100 k816 k

Revenue growth, %

1567%716%

Cost of goods sold

32 k154 k

Gross profit

68 k662 k
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

2.8 m2.5 m1.1 m5.9 m28 m24.2 m18.5 m10.3 m19.9 m

Accounts Receivable

6 k6 k2 k40 k398 k

Inventories

34 k64 k

Current Assets

2.8 m2.6 m1.3 m6.3 m28.4 m24.9 m19.6 m12.2 m22.3 m
GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(63 k)(2.2 m)(664 k)(5.4 m)(2.7 m)(3.5 m)(5.6 m)(7.6 m)(9.5 m)

Cash From Operating Activities

280 k(354 k)(755 k)(1.5 m)(2.1 m)(4.1 m)(5.6 m)(8.3 m)(8.9 m)

Cash From Financing Activities

3.1 m6.4 m24.2 m3 k8 k5 k19 m

Net Change in Cash

2.8 m(227 k)(714 k)4.8 m22.1 m(3.8 m)(5.7 m)(8.2 m)9.7 m
GBPY, 2016

Revenue/Employee

13.6 k

Financial Leverage

1.1 x
Show all financial metrics
Report incorrect company information

Tissue Regenix Group Online and Social Media Presence

Embed Graph
Report incorrect company information